SINGAPORE, April 16, 2023 /PRNewswire/ — “Decentralization is the essence of crypto and is the fundamental basis of how it solves many tradfi [traditional finance] issues. However, the inevitable trade-off is that it leads to a burdensome user experience, which only increases as you…
Month: April 2023
SHANGHAI, April 16, 2023 /PRNewswire/ — Abbisko (Stock Code: 2256.HK) announced the results of five latest preclinical studies at the 2023 American Association for Cancer Research (AACR) annual meeting. These include its self-developed CSF-1R inhibitor Pimicotinib (ABSK021), which has…
ROCKVILLE, Md. and SUZHOU, China, April 16, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic,…
SHANGHAI, April 16, 2023 /PRNewswire/ — As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched in China. Leveraging the differentiated competitive edges…
NEW YORK, April 16, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Wheels Up Experience Inc. (NYSE: UP) resulting from allegations that Wheels Up may have issued materially…
NEW YORK, April 16, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Mallinckrodt plc (NYSE American: MNK) resulting from allegations that Mallinckrodt may have issued materially…